SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,172,419 | -66.5% | 492,613 | -32.5% | 0.00% | – |
| Q2 2023 | $3,497,366 | +60.8% | 730,139 | +90.4% | 0.00% | – |
| Q1 2023 | $2,174,706 | +102.5% | 383,546 | +100.0% | 0.00% | – |
| Q4 2022 | $1,073,934 | -54.1% | 191,774 | -47.4% | 0.00% | – |
| Q3 2022 | $2,340,000 | +121.4% | 364,355 | +18.2% | 0.00% | – |
| Q2 2022 | $1,057,000 | -55.7% | 308,128 | -8.1% | 0.00% | – |
| Q1 2022 | $2,386,000 | -83.3% | 335,111 | -80.4% | 0.00% | – |
| Q4 2021 | $14,248,000 | +249.7% | 1,710,364 | +192.2% | 0.00% | – |
| Q3 2021 | $4,074,000 | -41.2% | 585,416 | +101.7% | 0.00% | – |
| Q2 2021 | $6,924,000 | +4.6% | 290,311 | -9.7% | 0.00% | – |
| Q1 2021 | $6,619,000 | -74.2% | 321,442 | -69.3% | 0.00% | -100.0% |
| Q4 2020 | $25,650,000 | +69.7% | 1,046,884 | +96.1% | 0.00% | 0.0% |
| Q3 2020 | $15,115,000 | +1167.0% | 533,918 | +113.1% | 0.00% | – |
| Q2 2020 | $1,193,000 | +1069.6% | 250,600 | +772.3% | 0.00% | – |
| Q1 2020 | $102,000 | -42.4% | 28,728 | -44.0% | 0.00% | – |
| Q4 2019 | $177,000 | -78.1% | 51,313 | -74.6% | 0.00% | – |
| Q3 2019 | $810,000 | -79.1% | 201,922 | -83.2% | 0.00% | – |
| Q2 2019 | $3,869,000 | +1065.4% | 1,201,233 | +2381.9% | 0.00% | – |
| Q1 2019 | $332,000 | +66.0% | 48,400 | +9.1% | 0.00% | – |
| Q4 2018 | $200,000 | -20.3% | 44,356 | +34.4% | 0.00% | – |
| Q3 2018 | $251,000 | -53.3% | 33,000 | -47.2% | 0.00% | – |
| Q2 2018 | $537,000 | -33.8% | 62,500 | -43.4% | 0.00% | – |
| Q1 2018 | $811,000 | -47.9% | 110,500 | -28.0% | 0.00% | – |
| Q4 2017 | $1,556,000 | -64.9% | 153,500 | -44.5% | 0.00% | -100.0% |
| Q3 2017 | $4,437,000 | +277.9% | 276,600 | +166.2% | 0.00% | – |
| Q2 2017 | $1,174,000 | +50.5% | 103,900 | +50.1% | 0.00% | – |
| Q1 2017 | $780,000 | -46.8% | 69,200 | -53.3% | 0.00% | – |
| Q4 2016 | $1,467,000 | -8.4% | 148,190 | +13.7% | 0.00% | – |
| Q3 2016 | $1,602,000 | -20.4% | 130,354 | +88.1% | 0.00% | -100.0% |
| Q2 2016 | $2,013,000 | +164.9% | 69,300 | +142.1% | 0.00% | – |
| Q1 2016 | $760,000 | -77.1% | 28,628 | -69.8% | 0.00% | -100.0% |
| Q4 2015 | $3,326,000 | +524.0% | 94,800 | +426.8% | 0.00% | – |
| Q3 2015 | $533,000 | – | 17,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $93,092,000 | 26.99% |
| ARK Investment Management | 2,406,723 | $17,665,000 | 0.88% |
| Virtus ETF Advisers LLC | 76,713 | $563,000 | 0.49% |
| Bison Wealth, LLC | 33,929 | $249,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,525 | $143,000 | 0.10% |
| Rock Springs Capital Management LP | 220,000 | $1,615,000 | 0.07% |
| FEDERATED HERMES, INC. | 1,766,681 | $12,968,000 | 0.04% |
| Spark Investment Management LLC | 79,500 | $583,000 | 0.04% |
| A.R.T. Advisors, LLC | 45,952 | $337,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 88,684 | $651,000 | 0.01% |